Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F LoBuglio

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Critical Care Medicine|December 1, 1990
Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndromeC J Fisher, J Zimmerman, M B Khazaeli, et al.
Human Antibodies and Hybridomas|January 1, 1992
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1994
Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49R F Meredith, A J Bueschen, M B Khazaeli, et al.
Blood|May 15, 1995
CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factorM N Saleh, S J Goldman, A F LoBuglio, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1991
Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibodyR F Meredith, A F LoBuglio, W E Plott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49R F Meredith, E E Partridge, R D Alvarez, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.
Gynecologic Oncology|April 1, 1997
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II studyR D Alvarez, E E Partridge, M B Khazaeli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerF Robert, M P Ezekiel, S A Spencer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Polynucleotide immunization of nonhuman primates against carcinoembryonic antigenR M Conry, S A White, P N Fultz, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Critical Care Medicine|December 1, 1990
Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndromeC J Fisher, J Zimmerman, M B Khazaeli, et al.
Human Antibodies and Hybridomas|January 1, 1992
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1994
Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49R F Meredith, A J Bueschen, M B Khazaeli, et al.
Blood|May 15, 1995
CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factorM N Saleh, S J Goldman, A F LoBuglio, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1991
Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibodyR F Meredith, A F LoBuglio, W E Plott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49R F Meredith, E E Partridge, R D Alvarez, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.
Gynecologic Oncology|April 1, 1997
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II studyR D Alvarez, E E Partridge, M B Khazaeli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerF Robert, M P Ezekiel, S A Spencer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Polynucleotide immunization of nonhuman primates against carcinoembryonic antigenR M Conry, S A White, P N Fultz, et al.
Pageof 17